Tomography (Sep 2023)

Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience

  • Antonella Meloni,
  • Laura Pistoia,
  • Amalia Lupi,
  • Riccardo Righi,
  • Antonino Vallone,
  • Massimiliano Missere,
  • Stefania Renne,
  • Priscilla Fina,
  • Ada Riva,
  • Maria Rita Gamberini,
  • Valerio Cecinati,
  • Francesco Sorrentino,
  • Rosamaria Rosso,
  • Giuseppe Messina,
  • Paolo Ricchi,
  • Vincenzo Positano,
  • Sophie Mavrogeni,
  • Emilio Quaia,
  • Filippo Cademartiri,
  • Alessia Pepe

DOI
https://doi.org/10.3390/tomography9050136
Journal volume & issue
Vol. 9, no. 5
pp. 1711 – 1722

Abstract

Read online

Background. The E-MIOT (Extension-Myocardial Iron Overload in Thalassemia) project is an Italian Network assuring high-quality quantification of tissue iron overload by magnetic resonance imaging (MRI). We evaluated the impact of the COVID-19 pandemic on E-MIOT services. Methods. The activity of the E-MIOT Network MRI centers in the year 2020 was compared with that of 2019. A survey evaluated whether the availability of MRI slots for patients with hemoglobinopathies was reduced and why. Results. The total number of MRI scans was 656 in 2019 and 350 in 2020, with an overall decline of 46.4% (first MRI: 71.7%, follow-up MRI: 36.9%), a marked decline (86.9%) in the period March–June 2020, and a reduction in the gap between the two years in the period July–September. A new drop (41.4%) was recorded in the period October–December for two centers, due to the general reduction in the total amount of MRIs/day for sanitization procedures. In some centers, patients refused MRI scans for fear of getting COVID. Drops in the MRI services >80% were found for patients coming from a region without an active MRI site. Conclusions. The COVID-19 pandemic had a strong negative impact on MRI multi-organ iron quantification, with a worsening in the management of patients with hemoglobinopathies.

Keywords